XML 75 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The components of the Company’s provision for income taxes for the years ended December 31, 2024 and 2023 consists of the following (in thousands):
December 31,
20242023
Current:
Federal$— $— 
United States— — 
Foreign— — 
          Total Current— — 
Deferred
Federal(11,236)7,743 
State1,192 3,116 
Foreign— — 
Change in valuation allowance
10,044 (10,859)
          Total Deferred— — 
                   Total tax provision$— $— 
Schedule of Effective Income Tax Rate Reconciliation
The reconciliations between the federal statutory income tax rate and the Company's effective income tax rate were as follows:
Year Ended December 31,
20242023
Statutory federal income tax rate
21.0 %21.0 %
State tax, net of federal benefits(2.4)%6.2 %
Permanent differences(3.5)%(0.3)%
Federal research and development credits3.6 %3.1 %
State research and development credits
0.6 %0.8 %
Other differences
0.1 %0.1 %
Change in valuation allowance(19.4)%(30.9)%
Effective income tax rate
0.0 %0.0 %
Schedule of Deferred Tax Assets and Liabilities
The principal components of the Company's net deferred tax asset at December 31, 2024 and 2023 were as follows (in thousands):
December 31,
20242023
Deferred tax assets (liabilities):
Net operating loss carryforwards
$64,646 $60,696 
Research and development tax credit carryovers
15,117 12,940 
Capitalized research and development
17,585 13,686 
Lease liability
1,548 1,897 
Other
2,704 2,732 
ROU asset
(1,470)(1,800)
Property and equipment(13)(33)
Total deferred tax assets
100,117 90,118 
Less: Deferred tax asset valuation allowance(100,117)(90,118)
Net deferred tax asset
$— $—